VHL Gene Mutation

3 registered clinical trials studyying VHL Gene Mutation.

Status	Trial	Sponsor	Phase
Withdrawn	Digoxin for Congenital Erythrocytosis Due to Up-Regulated Hypoxia Sensing NCT03433833	University of Illinois at Chicago	Phase 1
Active Not Recruiting	A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associate NCT03401788	Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 2
Completed	MK-3795 (PT2385) for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma (MK NCT03108066	Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 2